GlassScriptPhysician profile
Christopher C Chang
NPI 1851558670
$13,875.23
in general payments reported to CMS, 2019-2025
25 companies · $4,856 in 2025
The $4,856 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,871 · 2020: $778 · 2021: $1,299 · 2022: $2,349 · 2023: $1,316 · 2024: $406 · 2025: $4,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,084 · Consulting Fee: $2,433 · Travel and Lodging: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,083.51 |
| Consulting Fee | $2,433.01 |
| Travel and Lodging | $1,062.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,570.13 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Motiva USA, LLC | $2,530.50 | 2025 | |
| Sientra, INC. | $2,293.45 | 2020-2022 | |
| Allergan, INC. | $1,292.26 | 2019-2022 | |
| Medical Device Business Services, INC. | $1,083.94 | 2019 | |
| Integra Lifesciences Corporation | $791.84 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Galderma Laboratories, L.P. | $667.63 | 2019-2024 | Dysport |
| Smith+Nephew, INC. | $639.31 | 2019-2024 | Grafix, Stravix, Oasis |
| Mentor Worldwide LLC | $500.98 | 2019-2023 | Mentor Siltex Round Spectrum |
| Tepha INC | $218.47 | 2019 | |
| Axogen | $211.37 | 2022-2025 | |
| Access Pro Medical, LLC | $190.91 | 2025 | Matriderm |
| Solta Medical, A Division of Bausch Health US, LLC | $160.56 | 2022-2023 | |
| Acelrx Pharmaceuticals, INC. | $124.64 | 2019 | |
| Avita Medical Americas, LLC | $118.10 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $93.00 | 2019 | |
| Innovation Technologies INC | $87.81 | 2020 | |
| Tela Bio, INC. | $54.92 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Revance Therapeutics, INC. | $46.86 | 2025 | Daxxify |
| Lumenis, INC | $46.16 | 2021 | |
| Davol INC. | $39.66 | 2020-2021 | |
| Merz North America, INC. | $32.20 | 2019 | |
| Arteriocyte Medical Systems, INC. | $31.69 | 2020 | |
| Microaire Surgical Instruments LLC | $30.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.92 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.